UY26925A1 - Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones - Google Patents

Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones

Info

Publication number
UY26925A1
UY26925A1 UY26925A UY26925A UY26925A1 UY 26925 A1 UY26925 A1 UY 26925A1 UY 26925 A UY26925 A UY 26925A UY 26925 A UY26925 A UY 26925A UY 26925 A1 UY26925 A1 UY 26925A1
Authority
UY
Uruguay
Prior art keywords
compositions
mixtures
flavoring
flavoring systems
flavored
Prior art date
Application number
UY26925A
Other languages
English (en)
Spanish (es)
Inventor
Laman Alani
Donald P Gauwitz
Dilip Kaul
John M Lipari
Soumojeet Ghosh
Kennan C Marsh
Richard H Whelan
Vanik D Petrossian
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of UY26925A1 publication Critical patent/UY26925A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
UY26925A 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones UY26925A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65519200A 2000-09-05 2000-09-05

Publications (1)

Publication Number Publication Date
UY26925A1 true UY26925A1 (es) 2002-04-26

Family

ID=24627898

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26925A UY26925A1 (es) 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones

Country Status (10)

Country Link
EP (1) EP1315487A2 (fr)
JP (1) JP2004522698A (fr)
AR (1) AR030715A1 (fr)
AU (1) AU2001288695A1 (fr)
BR (1) BR0108433A (fr)
CA (1) CA2417258A1 (fr)
MX (1) MXPA03001952A (fr)
PE (1) PE20020373A1 (fr)
UY (1) UY26925A1 (fr)
WO (1) WO2002020057A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175205B1 (fr) 1999-11-12 2006-06-14 Abbott Laboratories Dispersion solide comrpenant ritonavir, fenofibrate ou griseofulvin
EP1565153A4 (fr) * 2002-11-22 2008-10-01 Noville Inc Compositions orales masquant la saveur salee de sels
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
TW201340998A (zh) * 2012-02-29 2013-10-16 Takeda Pharmaceutical 經口劑
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
WO1997046222A1 (fr) * 1996-06-03 1997-12-11 Merck & Co., Inc. Formulation pediatrique pour inhibiteurs de la protease du vih

Also Published As

Publication number Publication date
WO2002020057A3 (fr) 2002-05-10
AU2001288695A1 (en) 2002-03-22
MXPA03001952A (es) 2003-09-10
EP1315487A2 (fr) 2003-06-04
WO2002020057A2 (fr) 2002-03-14
CA2417258A1 (fr) 2002-03-14
AR030715A1 (es) 2003-09-03
BR0108433A (pt) 2006-06-06
JP2004522698A (ja) 2004-07-29
PE20020373A1 (es) 2002-05-13

Similar Documents

Publication Publication Date Title
JP5979763B2 (ja) ブロムヘキシンを含む水性組成物
KR970009800A (ko) 경구 투여용 약제학적 조성물
AR073793A1 (es) Formulacion farmaceutica liquida que contiene paracetamol. excipiente liquido
UY24813A1 (es) Nuevas preparaciones medicamentosas acuosas para la produccion de aerosoles libres de gas propulsor
UA79196C2 (en) Intranasal formulation of rotigotine
RU2008127860A (ru) Фармацевтический состав для содержащих серу лекарств в жидких дозированных формах
BR0211794A (pt) Composição farmacêutica e método para mascarar o sabor de pelo menos um composto farmaceuticamente ativo de sabor desagradável
PE20020307A1 (es) Forma de dosificacion de farmaco activada por hidrogel
RU2007148444A (ru) Педиатрическая композиция топирамата
UY26925A1 (es) Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones
PE20030545A1 (es) Formulaciones de jarabe de ribavirina
RU2009134333A (ru) Тиксотропные фармацевтические композиции
ES2312921T3 (es) Disolucion acuosa concentrada de ambroxol.
AR006345A1 (es) Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion.
ES2318277T3 (es) Composicion farmaceutica que compresnde acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico.
UA79110C2 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
JP2002348236A (ja) 医薬液剤
US20220218606A1 (en) Ready to use diclofenac stick packs
ES2310550T3 (es) Preparacion liquida acuosa de pranoprofeno.
CO5580751A2 (es) Nueva formulacion de jarabe de epinastina seco y acuoso
AR046665A1 (es) Formulaciones orales de desoxipeganina y sus usos
JP2001316265A (ja) オザグレルナトリウム含有注射液およびその安定化方法
AR025393A1 (es) Pildoras de desintegracion rapida basadas en quitosan
ES2194899T3 (es) Composicion farmaceutica para administracion transdermica sistemica del principio activo morfina-6-glucuronido.
KR20000016365A (ko) 니메술리드를 함유하는 경구 투여용 약제학적 제제

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150424